Home › Funds › VICTORY CAPITAL MANAGEMENT INC › ELV

VICTORY CAPITAL MANAGEMENT INC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

VICTORY CAPITAL MANAGEMENT INC reported holding 1,701,589 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$661.6M, representing 0.38% of its reported portfolio and ranking #49 among its reported holdings. VICTORY CAPITAL MANAGEMENT INC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.70M sh
Reported value held$661.61M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VICTORY CAPITAL MANAGEMENT INC's ELV position evolved

VICTORY CAPITAL MANAGEMENT INC first disclosed a stake in ELV in Q3 2023 at 175,138 shares (US$76.3M). The position peaked in Q3 2026 at 1,701,589 shares, worth US$661.6M. Across 13 filings, VICTORY CAPITAL MANAGEMENT INC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,701,589 shares valued at US$661.6M — an increase of 1,080,331 shares quarter over quarter.. Notable position changes include a 179% increase in Q2 2025 (shares fell 16% over the following quarter), a 135% increase in Q2 2026 (shares were roughly flat over the following quarter), a 174% increase in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 175.14K $76.26M New
Q4 2023 187.41K $88.37M Add
Q1 2024 167.81K $87.02M Reduce
Q2 2024 194.19K $105.22M Add
Q3 2024 203.04K $105.58M Add
Q4 2024 251.29K $92.70M Add
Q1 2025 126.43K $54.99M Reduce
Q2 2025 352.23K $136.96M Add
Q3 2025 461.69K $149.18M Add
Q4 2025 127.78K $44.79M Reduce
Q1 2026 264.30K $77.37M Add
Q2 2026 621.26K $240.26M Add
Q3 2026 1.70M $661.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has VICTORY CAPITAL MANAGEMENT INC held ELV?

VICTORY CAPITAL MANAGEMENT INC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VICTORY CAPITAL MANAGEMENT INC's current position in ELV?

As of Q3 2026, VICTORY CAPITAL MANAGEMENT INC holds 1.70M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $661.61M, representing 0.38% of its reported portfolio and ranking #49.

Has VICTORY CAPITAL MANAGEMENT INC been buying or selling ELV?

In the latest 13F filing (Q3 2026), VICTORY CAPITAL MANAGEMENT INC increased its position in ELV. The position peaked in Q3 2026 at 1.70M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.